INTERVENTIONS TO IMPROVE MEDICATION COMPLIANCE IN HYPERTENSION- QUALITATIVE AND QUANTITATIVE SYSTEMATIC REVIEW

Author(s)

Femida Gwadry-Sridhar, BScPhm, MSc, PhD, Assistant Professor1, Lincy S. Lal, PhD, Research Specialist2, Elizabeth Manias, MPharm, PhD, Professor, Associate Head of Research3, Maribel Salas, MD, DSc, MSc, Associate Medical Director41University of Western Ontario, London, ON, Canada; 2 University of Texas MD Anderson Cancer Center, Houston, TX, USA; 3 University of Melbourne, Carlton, Australia; 4 AstraZeneca, LP, Wilmington, DE, USA

OBJECTIVES The objective of this systematic review was to evaluate the impact of interventions to improve medication compliance in patients on antihypertensive medications. METHODS CINAHL, EMBASE, all EBM Reviews and MEDLINE electronic databases were searched for articles published January 1979 through February 2007 using MeSH keywords relevant to patient compliance and intervention type, yielding 405 citations. Two reviewers independently examined each citation and abstract. We conducted three levels of review resulting in 94 papers for full review. Data were analyzed using qualitative and quantitative methods, including a meta-analysis using a random effects model (REM) and Mantel-Haenszel (MH) summary estimate. RESULTS The most common research design involved randomized controlled trials (RCTs) (60/94, 64%). Seventy-two (77%) studies involved interventions that sought to directly improve medication compliance, 12 (13%) had to do with interventions to improve compliance through a multidisciplinary process, 5 (5%) involved interventions to indirectly improve compliance through changing physician practice, and 5 (5%) were other types. Thirteen studies (14%) involved the use of a theoretical framework to guide the research. A meta-analysis was conducted of RCTs of educational interventions, (N=6). The REM showed a trend toward statistical significance with a risk ratio of 0.83 for non-compliance (95% CI: 0.68 -1.00, p=0.05). The MH summary estimate was statistically significant with a risk ratio of 0.83 for non-compliance (95% CI: 0 .75 - 0.92, p=0.00), favoring patients who received educational interventions to improve compliance. However, the X2 test for heterogeneity was significant; p=0.020 and p=0.016 respectively. CONCLUSIONS Our analysis indicated that most interventions focused on directly improving medication compliance. The meta-analysis illustrated educational strategies provide a significant benefit in reducing non-compliance in patients using antihypertensives. The small sample size may have contributed to the observed heterogeneity and require additional investigation. Our findings have implications for designing future research and implementing educational interventions.

Conference/Value in Health Info

2009-05, ISPOR 2009, Orlando, FL, USA

Value in Health, Vol. 12, No. 3 (May 2009)

Code

PCV78

Topic

Patient-Centered Research

Topic Subcategory

Adherence, Persistence, & Compliance

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×